Company: CERO
Filing Date: 2025-11-19
Form Type: 10-Q
Source: 0001213900-25-112619
Chunk: 47

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-11-19
Form: 10-Q
Item: Item 1
Chunk 47
---
 of the Common Stock underlying the Series D Preferred Stock is calculated
using the greatest closing sale price of the Common Stock on any trading day immediately preceding such bankruptcy Series D
Triggering Event and the date the Company makes the entire payment required.

Change of Control Exchange.
Upon a change of control of the Company, each holder may require the Company to exchange the holder’s shares of Series D Preferred
Stock for consideration equal to the Change of Control Election Price (as defined in the Series D Certificate of Designations), to
be satisfied at the Company’s election in either (x) cash or (y) rights convertible into such securities or other assets
to which such holder would have been entitled with respect to such shares of Common Stock had such shares of Common Stock been held by
such holder upon consummation of such corporate event.

Company Optional Redemption.
At any time the Company shall have the right to redeem in cash all, but not less than all, the shares of Series D Preferred Stock
then outstanding at a 25% redemption premium to the greater of (x) the amount of shares being redeemed, and (y) the equity value
of the Common Stock underlying the Series D Preferred Stock. The equity value of the Common Stock underlying the Series D Preferred
Stock is calculated using the greatest closing sale price of the Common Stock on any trading day immediately preceding the date the
Company notifies the holders of the Company’s election to redeem and the date the Company makes the entire payment required.

Fundamental Transactions.
The Certificate of Designations prohibit the Company from entering specified fundamental transactions (including, without limitation,
mergers, business combinations and similar transactions) unless the Company (or the Company’s successor) assumes in writing all
of the Company’s obligations under the Certificate of Designations and the other Transaction Documents (as defined in the Series D
Certificate of Designations).

Voting Rights. The
holders of the Series D Preferred Stock shall have no voting power and no right to vote on any matter at any time, either as a separate
series or class or together with any other series or class of share of capital stock, and shall not be entitled to call a meeting of such
holders for any purpose nor shall they be entitled to participate in any meeting of the holders of Common Stock, except as provided in
the Certificate of Designations (or as otherwise required by applicable law).

Covenants. The Series D
Certificate of Designations contains a